Your session is about to expire
← Back to Search
Cycling at a Moderate Intensity Aerobic Exercise (AE) group for Diabetic Neuropathy (EIHDM Trial)
N/A
Waitlist Available
Led By Marlon L. Wong, PhD
Research Sponsored by University of Miami
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 20 minutes
Awards & highlights
EIHDM Trial Summary
The purpose of this research study is to learn whether different forms of exercise can reduce pain experienced by individuals with painful diabetic peripheral neuropathy.
Eligible Conditions
- Diabetic Neuropathy
EIHDM Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ baseline, 20 minutes
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 20 minutes
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Change in Pain Pressure Threshold (PPT)
Secondary outcome measures
Change in Heat Pain Threshold (HPT)
EIHDM Trial Design
2Treatment groups
Experimental Treatment
Group I: Cycling at a Moderate Intensity Aerobic Exercise (AE) groupExperimental Treatment1 Intervention
All participants will be asked to cycle during the first phase at a moderate intensity for 20 minutes.
Group II: Blood Flow restriction training with cycling at a moderate intensity (BFR+AE) groupExperimental Treatment2 Interventions
All participants will be asked to wear an automated personalize tourniquet system to restrict blood flow. Participants will be asked to lie in supine and a non-shedding stockinette protection sleeve will be placed at bilateral proximal thighs. Then, participants will be asked to cycle at a moderate intensity for 20 minutes during the second phase.
Find a Location
Who is running the clinical trial?
University of MiamiLead Sponsor
902 Previous Clinical Trials
410,076 Total Patients Enrolled
Marlon L. Wong, PhDPrincipal InvestigatorUniversity of Miami
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Share this study with friends
Copy Link
Messenger